China's Premier Center for Pancreatic Surgery
The Department of Pancreatic Surgery at Changhai Hospital — affiliated with Naval Medical University (Second Military Medical University) — is one of China's most distinguished and highest-volume pancreatic surgery centers, with a national and international reputation for excellence in pancreaticoduodenectomy (Whipple procedure), distal pancreatectomy, total pancreatectomy, minimally invasive pancreatic surgery, pancreatic cancer surgery, and the surgical management of chronic pancreatitis, pancreatic cysts, and pancreatic neuroendocrine tumors. Consistently ranked among China's top pancreatic surgery programs by annual volume and outcomes, Changhai Hospital's pancreatic surgery department offers international patients access to some of China's most eminent pancreatic surgeons and the latest surgical techniques.
For international patients with pancreatic cancer, chronic pancreatitis, a pancreatic cyst, a pancreatic neuroendocrine tumor, or a complex pancreatic condition requiring surgery — Changhai Hospital's pancreatic surgery department offers an unparalleled combination of surgical expertise, volume, and multidisciplinary integration with China's premier digestive endoscopy center. China Medical Concierge Shanghai (CMCS) provides seamless end-to-end coordination for international patients throughout their pancreatic surgical care journey at Changhai Hospital.
About the Department
Changhai Hospital's pancreatic surgery department is a national key clinical specialty performing hundreds of major pancreatic resections annually, making it one of the highest-volume pancreatic surgery programs in China. The department operates dedicated pancreatic surgery wards, a pancreatic surgical intensive care unit, multiple minimally invasive surgical theaters with laparoscopic and robotic capability, and works in close collaboration with the digestive endoscopy center, gastroenterology, oncology, interventional radiology, and pathology through a fully integrated multidisciplinary pancreatic tumor board.
Faculty members publish regularly in leading surgery and pancreatology journals including Annals of Surgery, JAMA Surgery, British Journal of Surgery, Pancreatology, and Journal of Gastrointestinal Surgery.
Pancreatic Surgery Programs
Pancreaticoduodenectomy (Whipple Procedure)
- Standard Pancreaticoduodenectomy (PD) — Classic Whipple with antrectomy; pylorus-preserving pancreaticoduodenectomy (PPPD); pancreaticojejunostomy reconstruction (duct-to-mucosa, invagination); hepaticojejunostomy; gastrojejunostomy
- Laparoscopic Pancreaticoduodenectomy (LPD) — Minimally invasive Whipple; reduced blood loss and faster recovery; one of China's highest-volume LPD programs
- Robotic Pancreaticoduodenectomy (RPD) — da Vinci robotic-assisted Whipple; superior ergonomics for intracorporeal anastomosis; precise dissection around superior mesenteric vessels
- Extended PD with Vascular Resection — Superior mesenteric vein (SMV) and portal vein (PV) resection and reconstruction for borderline resectable pancreatic cancer; arterial resection (SMA, celiac axis) for selected cases
- Indications — Pancreatic head cancer; ampullary cancer; distal cholangiocarcinoma; duodenal cancer; chronic pancreatitis with head mass; IPMN of the pancreatic head; pancreatic neuroendocrine tumors of the head
Distal Pancreatectomy
- Laparoscopic Distal Pancreatectomy (LDP) — Spleen-preserving (Kimura technique with splenic vessel preservation; Warshaw technique with splenic vessel ligation) and splenectomy; stapler and hand-sewn pancreatic stump closure; one of China's highest-volume LDP programs
- Robotic Distal Pancreatectomy (RDP) — Robotic-assisted spleen-preserving distal pancreatectomy; superior visualization for splenic vessel dissection
- Radical Antegrade Modular Pancreatosplenectomy (RAMPS) — For left-sided pancreatic cancer; anterior and posterior RAMPS; improved R0 resection rates and lymph node harvest
- Indications — Pancreatic body and tail cancer; pancreatic neuroendocrine tumors; serous and mucinous cystic neoplasms; IPMN of the body and tail; chronic pancreatitis
Total Pancreatectomy
- Total Pancreatectomy (TP) — For multifocal IPMN; diffuse pancreatic cancer; hereditary pancreatitis; post-operative pancreatic fistula after PD
- Total Pancreatectomy with Islet Autotransplantation (TP-IAT) — Islet cell isolation and portal vein infusion to preserve endogenous insulin secretion; for chronic pancreatitis with intractable pain; reduces severity of post-pancreatectomy diabetes
- Laparoscopic Total Pancreatectomy — Minimally invasive approach for selected cases
Parenchyma-Preserving Pancreatic Resections
- Central Pancreatectomy — For benign and low-grade malignant tumors of the pancreatic neck and proximal body; preserves pancreatic head and tail function; reduces risk of post-operative diabetes and exocrine insufficiency
- Enucleation — For small benign tumors (insulinomas, small non-functioning NETs, serous cystadenomas) away from the main pancreatic duct; laparoscopic and robotic enucleation
- Duodenum-Preserving Pancreatic Head Resection (DPPHR) — Beger and Frey procedures for chronic pancreatitis with head mass; preserves duodenum and bile duct; superior quality of life vs. Whipple for chronic pancreatitis
Pancreatic Cancer Surgery
Resectable Pancreatic Cancer
- Upfront Surgery — PD or DP for clearly resectable tumors; R0 resection as primary goal; extended lymphadenectomy; intraoperative frozen section for margin assessment
- Adjuvant Chemotherapy — Modified FOLFIRINOX; gemcitabine + capecitabine; coordination with oncology for post-operative systemic therapy
Borderline Resectable Pancreatic Cancer (BRPC)
- Neoadjuvant Therapy — FOLFIRINOX or gemcitabine + nab-paclitaxel induction; restaging CT after 4-6 cycles; conversion surgery for responders
- Vascular Resection & Reconstruction — SMV/PV resection with primary anastomosis or interposition graft; arterial resection for selected cases
- SBRT Consolidation — Stereotactic body radiation therapy before surgery for local control
Locally Advanced Pancreatic Cancer (LAPC)
- Conversion Surgery — Aggressive neoadjuvant chemotherapy (FOLFIRINOX, NALIRIFOX) ± radiation; conversion to resectability in selected responders; arterial resection for selected cases
- HAIC (Hepatic Arterial Infusion Chemotherapy) — For liver-dominant metastatic disease; coordination with interventional radiology
- Irreversible Electroporation (IRE/NanoKnife) — For LAPC abutting major vessels not amenable to resection; local ablation with vessel preservation
Chronic Pancreatitis Surgery
- Frey Procedure (Local Resection + Lateral Pancreaticojejunostomy) — For chronic pancreatitis with dilated main pancreatic duct and head mass; superior pain relief and preservation of pancreatic function vs. Whipple
- Beger Procedure (DPPHR) — Duodenum-preserving pancreatic head resection for inflammatory head mass
- Lateral Pancreaticojejunostomy (Puestow-Gillesby) — For dilated main pancreatic duct without head mass; duct decompression
- Total Pancreatectomy with Islet Autotransplantation (TP-IAT) — For end-stage chronic pancreatitis with intractable pain; islet preservation to minimize post-operative diabetes
- Thoracoscopic Splanchnicectomy — For intractable pain in chronic pancreatitis not amenable to ductal decompression
Pancreatic Cysts & IPMN
- Intraductal Papillary Mucinous Neoplasm (IPMN) — Main duct IPMN: resection recommended; branch duct IPMN: surveillance vs. resection based on Fukuoka/European guidelines; mixed-type IPMN; total pancreatectomy for multifocal high-risk IPMN
- Mucinous Cystic Neoplasm (MCN) — Resection for all MCN in fit patients; laparoscopic distal pancreatectomy preferred
- Serous Cystadenoma (SCA) — Surveillance for asymptomatic SCA; resection for symptomatic or rapidly growing lesions; enucleation for small lesions
- Solid Pseudopapillary Neoplasm (SPN) — Resection for all SPN; excellent prognosis; laparoscopic approach preferred
- EUS-Guided Cyst Ablation — EUS-guided ethanol + paclitaxel ablation for selected branch duct IPMN and MCN; coordination with endoscopy center
Pancreatic Neuroendocrine Tumors (pNET)
- Insulinoma — Enucleation for small sporadic insulinomas; laparoscopic enucleation; intraoperative ultrasound for localization; distal pancreatectomy for body/tail insulinomas
- Non-Functioning pNET — Resection for tumors >2cm; surveillance for small (≤2cm) non-functioning pNET; parenchyma-preserving resection for benign tumors
- Gastrinoma (Zollinger-Ellison Syndrome) — Surgical resection for sporadic gastrinoma; MEN1-associated gastrinoma management; proton pump inhibitor therapy
- VIPoma, Glucagonoma, Somatostatinoma — Surgical resection; somatostatin analogues for symptom control
- MEN1-Associated pNET — Surveillance; resection for tumors >2cm; subtotal pancreatectomy for diffuse disease
- Advanced pNET — Cytoreductive surgery; Lu-177 DOTATATE PRRT; everolimus; sunitinib; coordination with oncology
Unique Integration: Surgery + Endoscopy
Changhai Hospital's unique strength is the seamless integration of China's premier pancreatic surgery program with China's premier digestive endoscopy center under one roof. This integration enables:
- Pre-operative EUS-FNB for tissue diagnosis and molecular profiling
- EUS-guided celiac plexus neurolysis for pre-operative pain management
- ERCP biliary drainage before surgery for jaundiced patients
- Post-operative ERCP for pancreatic fistula and biliary complications
- EUS-guided drainage of post-operative fluid collections and walled-off necrosis
- Endoscopic management of post-pancreatectomy complications without re-operation
Why International Patients Choose Changhai Pancreatic Surgery
- High-Volume Program — One of China's highest-volume pancreatic surgery programs with outcomes benchmarked against international standards
- Minimally Invasive Expertise — High-volume laparoscopic and robotic PD, DP, and enucleation
- Vascular Resection — SMV/PV resection for borderline resectable pancreatic cancer; arterial resection for selected cases
- TP-IAT — Total pancreatectomy with islet autotransplantation for chronic pancreatitis
- Endoscopy Integration — Unique seamless integration with China's premier digestive endoscopy center
- Cost-Effectiveness — World-class pancreatic surgery at significantly lower cost than equivalent treatment in Western countries
The CMCS Patient Journey
- Initial Inquiry — Share your pancreatic diagnosis, CT/MRI/MRCP imaging, EUS reports, pathology, CA19-9, and prior treatment history with CMCS.
- Medical Record Preparation — We translate and organize your records for specialist pre-consultation review.
- MDT Submission — We facilitate pre-arrival case review by Changhai's pancreatic tumor board (surgery + endoscopy + oncology + radiology).
- Specialist Matching — We identify the most appropriate pancreatic surgeon based on your diagnosis and planned procedure.
- Priority Scheduling — We secure a consultation and surgical slot with minimal waiting time.
- Travel & Logistics — Assistance with visa invitation letters, accommodation near Changhai Hospital, and Shanghai airport transfers.
- Surgical Coordination — Full coordination of pre-operative assessment, surgical admission, and post-operative care.
- Post-Operative Follow-Up — Pathology report translation, adjuvant therapy coordination, and remote follow-up after you return home.
Book a Consultation
If you have pancreatic cancer, chronic pancreatitis, a pancreatic cyst, a pancreatic neuroendocrine tumor, or a complex pancreatic condition requiring surgery — CMCS can arrange a specialist consultation with Changhai Hospital's pancreatic surgery team in Shanghai.
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
댓글 0개